Concepedia

Miho Hiraki

MH

8

Publications

344

Citations

8

H-Index

2005

Active since

Affiliations

Shimane University(Current)

San Francisco VA Medical Center

University of California, San Francisco

The University of Osaka

Yonsei University

Miho Hiraki is an author at Shimane University specializing in tumor biology, medicine, and cell signaling.

Top concepts

Publications per year

2005–2017

8

Publications

8

Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma

Yozo Mitsui, Hiroaki Shiina, Taku Kato et al. · Molecular Cancer Research · 2017 · 90 citations · Full text

Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition

Hiroki Tamaki, Nanae Harashima, Miho Hiraki et al. · Oncotarget · 2014 · 80 citations · Full text

CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma

Yozo Mitsui, Inik Chang, Shinichiro Fukuhara et al. · BMC Cancer · 2015 · 54 citations · Full text

Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones

Shanshan Cai, Katsumasa Sato, Toshiaki Shimizu et al. · Journal of Antimicrobial Chemotherapy · 2005 · 49 citations · Full text

Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways

Yozo Mitsui, Hiroshi Hirata, Naoko Arichi et al. · Oncotarget · 2015 · 26 citations · Full text

Rows per page

1–5 of 8